CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...
Phase 3
Roma, Italy and 83 other locations
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
Roma, Italy and 83 other locations
Primary Objective:* To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a p...
Phase 3
Roma, Italy and 79 other locations
to budesonide in children from 6 to less than 12 years of age with asthma.* The study duration will be up to 37 weeks including an investiga...
Phase 3
Roma, RM, Italy and 51 other locations
This is a study of amlitelimab for the treatment of participants with moderate-to-severe asthma. The study will have a double-blind treatmen...
Phase 2
Roma, Italy and 67 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Rome, Roma, Italy and 57 other locations
with amlitelimab in adult participants with moderate-to-severe asthma.Study details include:* The study duration (per participant) will be u...
Phase 2
Roma, Lazio, Italy and 122 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Roma, Italy and 381 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Roma, Italy and 419 other locations
propellant (HFA-152a) compared to the currently approved one (HFA-134a) in the medication (CHF5993) in patients with moderate to severe asthma...
Phase 3
Roma, Italy and 142 other locations
Clinical trials
Research sites
Resources
Legal